Jinyu Bio-technology Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jing Zhang
Chief executive officer
CN¥1.4m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6yrs |
| CEO ownership | 0.5% |
| Management average tenure | 5.8yrs |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
CEO
Jing Zhang (41 yo)
6yrs
Tenure
CN¥1,392,300
Compensation
Ms. Jing Zhang serves as President of Jinyu Bio-technology Co., Ltd. since May 2019 and is its Vice Chairman. She serves as Director of Jinyu Bio-technology Co., Ltd.since May 2016 and served as its Vice...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & President | 6yrs | CN¥1.39m | 0.55% CN¥ 42.8m | |
| CFO, Secretary of the Board of Directors & Director | 3yrs | CN¥1.62m | no data | |
| Vice President | 5.8yrs | CN¥660.00k | 0.075% CN¥ 5.8m |
5.8yrs
Average Tenure
41yo
Average Age
Experienced Management: 600201's management team is seasoned and experienced (5.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Vice Chairman & President | 9yrs | CN¥1.39m | 0.55% CN¥ 42.8m | |
| CFO, Secretary of the Board of Directors & Director | 3yrs | CN¥1.62m | no data | |
| Chairman | no data | CN¥1.59m | 2.06% CN¥ 160.6m | |
| Supervisor | 3yrs | CN¥238.80k | 0.012% CN¥ 935.7k | |
| Independent Director | 3yrs | CN¥136.80k | no data | |
| Supervisor | 3yrs | no data | 0.0032% CN¥ 251.1k | |
| Director | 3yrs | CN¥1.39m | 0.018% CN¥ 1.4m | |
| Independent Director | 3yrs | CN¥75.50k | no data | |
| Independent Director | 2.3yrs | no data | no data |
3.0yrs
Average Tenure
48yo
Average Age
Experienced Board: 600201's board of directors are considered experienced (3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/09 01:36 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jinyu Bio-technology Co., Ltd. is covered by 13 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Fu Yang | Chasing Securities |
| Xie Zhiyou | China Galaxy Securities Co., Ltd. |